Source: s3://data.kl3m.ai/documents/govinfo/USCOURTS/USCOURTS-cand-5_19-cv-00253/USCOURTS-cand-5_19-cv-00253-0/pdf.json

Nature of Suit Code: 367
Nature of Suit: TORTS - Personal Injury - Health Care/Pharmaceutical Personal Injury/Product Liability
Cause of Action: 28:1332 Diversity-Product Liability

---

Case MDL No. 2875 Document 234 Filed 02/25/19 Page 1 of 3 

UNITED ST ATES JUDICIAL PANEL 

on 

MULTIDISTRICT LITIGATION 

IN RE: V ALSARTAN PRODUCTS LIABILITY 

LITIGATION 

(SEE A TT ACHED SCHEDULE) 

CONDITIONAL TRANSFER ORDER (CTO -1) 

MDL No. 2875 

On February 14, 2019, the Panel transferred 5 civil action(s) to the United States District Court for 

the District of New Jersey for coordinated or consolidated pretrial proceedings pursuant to 28 U.S.C. 

§ 1407. See _F.Supp.3d_ (J.P.M.L. 2019). Since that time, no additional action(s) have been 

transferred to the District of New Jersey. With the consent of that court, all such actions have been 

assigned to the Honorable Robert B. Kugler. 

It appears that the action(s) on this conditional transfer order involve questions of fact that are 

common to the actions previously transferred to the District of New Jersey and assigned to Judge 

Kugler. 

Pursuant to Rule 7 .1 of the Rules of Procedure of the United States Judicial Panel on Multidistrict 

Liti~ation, the action(s) on the attached schedule are transferred under 28 U.S.C. § 1407 to the 

District of New Jersey for the reasons stated in the order of February 14, 2019, and, with the consent 

of that court, assigned to the Honorable Robert B. Kugler. 

This order does not become effective until it is filed in the Office of the Clerk of the United States 

District Court for the District of New Jersey. The transmittal of this order to said Clerk shall be 

stayed 7 days from the entry thereof. If any party files a notice of opposition with the Clerk of the 

Panel within this 7-day period, the stay will be continued until further order of the Panel. 

Inasmuch as no objection is 

pending at this time, the 

stay is lifted. 

Feb 25, 2019 

CLERK'S OFFICE UNITED STATES 

JUDICIAL PANEL ON 

MULTIDISTRICT LITIGATION 

FOR THE PANEL: 

~-

Jeffery N. Luthi 

Clerk of the Panel 

Case 5:19-cv-00253-NC Document 4 Filed 02/26/19 Page 1 of 3
Case MDL No. 2875 Document 234 Filed 02/25/19 Page 2 of 3 

IN RE: VALSARTAN PRODUCTS LIABILITY 

LITIGATION MDL No. 2875 

SCHEDULE CT0-1 -TAG-ALONG ACTIONS 

C.A.NO, 

ALABAMA NORTHERN 

ALN 5 19-00150 

ARKANSAS WESTERN 

ARW 2 19-02017 

CALIFORNIA CENTRAL 

CAC 8 19-00180 

CALIFORNIA EASTERN 

CAE 1 19-00212 

CALIFORNIA NORTHERN 

CAN 5 19-00253 

FLORIDA MIDDLE 

FLM 2 18-00710 

FLORIDA NORTHERN 

FLN 4 19-00023 

FLORIDA SOUTHERN 

FLS 18-25260 

GEORGIA NORTHERN 

CASE CAPTION 

Sen v. Zhejiang Huahai Pharmaceutical Co LTD et al 

Selph v. Zhejiang Huahai Pharmaceutical Co., Ltd. et al 

Daniel Winiecki v. Zhejiang Huahai Pharmaceutical 

Co., LTD. et al 

Avedikian v. Zhejiang Huahai Pharmaceutical Co., Ltd 

et al 

Guiton v. Zhejiang Huahai Pharmaceutical Co., Ltd et al 

Molinaro v. Prinston Pharmaceutical Inc. et al 

BARBER v. ZHEJIANG HUAHAI 

PHARMACEUTICAL CO LTD et al 

MSP Recovery Claims, Series LLC v. Huahai US Inc. et 

al 

Case 5:19-cv-00253-NC Document 4 Filed 02/26/19 Page 2 of 3
Case MDL No. 2875 Document 234 Filed 02/25/19 Page 3 of 3 

GAN 

INDIANA SOUTHERN 

INS 

INS 

1 

4 

LOUISIANA EASTERN 

LAE 2 

LAE 2 

LOUISIANA WESTERN 

LAW 6 

MASSACHUSETTS 

MA 1 

MA 1 

MA 3 

MINNESOTA 

MN 0 

NEW YORK EASTERN 

NYE 

NYE 

2 

2 

OHIO NORTHERN 

OHN 3 

19-00475 

19-00279 

19-00022 

19-00078 

19-00322 

18-01497 

18-12339 

19-10074 

19-30014 

19-00091 

18-06916 

19-00332 

19-00233 

PENNSYLVANIA WESTERN 

PAW 2 19-00046 

TENNESSEE EASTERN 

TNE 3 19-00040 

Martey v. Zhejiang Huahai Pharmaceutical Co., Ltd. et 

al 

BAKER v. MYLAN INC. et al 

WILLIAMS v. ZHEJIANG HUAHAI 

PHARMACEUTICALS CO., LTD. et al 

Slavich v. Zhejiang Huahai Pharmaceutical Co., Ltd. et 

al 

Kleinman v. Zhejiang Huahai Pharmaceutical Co., Ltd. 

et al 

Gremillion v. Zhejiang Huahai Pharmaceutical Co Ltd 

et al 

Longwell v. Camber Pharmaceuticals, Inc. et al 

Barboza et al v. Zhejiang Huahai Pharmaceutical Co., 

Ltd. et al 

Williams v. Zhejiang Huahai Pharmaceutical Co., Ltd. 

et al 

Tack et al v. Zhejiang Huahai Pharmaceutical Co., Ltd. 

et al 

Cacaccio v. Mylan Pharmaceuticals, Inc. et al 

Nelson v. Teva Pharmaceutical Industries, Ltd. et al 

Pollock v. Zhejiang Huahai Pharmaceutical Co., Ltd et 

al 

RODICH-ANNESE v. SOLO HEALTHCARE U.S., 

LLC et al 

Holland et al v. Zhejiang Huahai Pharmaceutical Co., 

Ltd. et al (JRG3) 

Case 5:19-cv-00253-NC Document 4 Filed 02/26/19 Page 3 of 3